James Kihara insider trades
Open-market stock purchases and sales by James Kihara, PRINCIPAL ACCOUNTING OFFICER at Acadia Pharmaceuticals Inc, from SEC Form 4 filings since Feb 23, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 26, 2026 | ACAD Acadia Pharmaceuticals Inc | Sold | $298K |
| May 26, 2026 | ACAD Acadia Pharmaceuticals Inc | Sold | $114K |
| May 4, 2026 | ACAD Acadia Pharmaceuticals Inc | Sold | $29K |
| May 1, 2026 | ACAD Acadia Pharmaceuticals Inc | Bought (not open market) | — |
| Apr 7, 2026 | ACAD Acadia Pharmaceuticals Inc | Sold | $22.9K |
| Apr 5, 2026 | ACAD Acadia Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 26, 2026 | ACAD Acadia Pharmaceuticals Inc | Sold | $23.8K |
| Mar 26, 2026 | ACAD Acadia Pharmaceuticals Inc | Sold | $261 |
| Mar 25, 2026 | ACAD Acadia Pharmaceuticals Inc | Sold | $17.9K |
| Mar 25, 2026 | ACAD Acadia Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 24, 2026 | ACAD Acadia Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 6, 2026 | ACAD Acadia Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 6, 2026 | ACAD Acadia Pharmaceuticals Inc | Bought (not open market) | — |
| Nov 18, 2025 | ACAD Acadia Pharmaceuticals Inc | Sold | $96.8K |
| Nov 17, 2025 | ACAD Acadia Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- ACAD Acadia Pharmaceuticals Inc: 28 sales, last Jun 26, 2026